Effect of Enteric Coating on Antiplatelet Activity of Low-Dose Aspirin in Healthy Volunteers
- 1 August 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 37 (8) , 2153-2158
- https://doi.org/10.1161/01.str.0000231683.43347.ec
Abstract
Background and Purpose— Aspirin resistance may be relatively common and associated with adverse outcome. Meta-analysis has clearly shown that 75 mg plain aspirin is the lowest effective dose; howev...Keywords
This publication has 24 references indexed in Scilit:
- Platelet Response to Low-Dose Enteric-Coated Aspirin in Patients With Stable Cardiovascular DiseaseJournal of the American College of Cardiology, 2005
- Cyclooxygenase-1 haplotype modulates platelet response to aspirinJournal of Thrombosis and Haemostasis, 2005
- Analysis of Risk of Bleeding Complications After Different Doses of Aspirin in 192,036 Patients Enrolled in 31 Randomized Controlled TrialsThe American Journal of Cardiology, 2005
- Effects of enteric-coated, low-dose aspirin on parameters of platelet functionAlimentary Pharmacology & Therapeutics, 2002
- AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 UpdateCirculation, 2002
- Role of Prostacyclin in the Cardiovascular Response to Thromboxane A 2Science, 2002
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- DipyridamoleNew England Journal of Medicine, 1987
- Dose-Related Kinetics of AspirinNew England Journal of Medicine, 1984
- Selective Cumulative Inhibition of Platelet Thromboxane Production by Low-dose Aspirin in Healthy SubjectsJournal of Clinical Investigation, 1982